Target intelligence / Profile preview

Cardiomyocyte calcium homeostasis

Molecular classification
Ion channel, Transporter, Enzyme, Regulatory protein
01

Overview

Cardiomyocyte calcium homeostasis is the complex physiological process that regulates the concentration and movement of calcium ions (Ca2+) within cardiac muscle cells, serving as the bridge between electrical excitation and mechanical contraction, known as excitation-contraction coupling (ECC) (Bers, 2002, Nature). This system relies on the coordinated activity of several key proteins: L-type calcium channels (LTCC) facilitate initial Ca2+ entry, which triggers a larger release of Ca2+ from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyR2) (Eisner et al., 2017, Circ Res). For relaxation to occur, Ca2+ must be removed from the cytoplasm, primarily through reuptake into the SR by the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2a) and extrusion via the sodium-calcium exchanger (NCX) (Marks, 2013, JCI). Dysregulation of these pathways, such as leaky RyR2 channels or reduced SERCA2a activity, is a primary driver of contractile dysfunction in heart failure and provides a substrate for triggered arrhythmias (Landstrom et al., 2017, Nat Rev Cardiol). Therapeutic strategies targeting this process include calcium channel blockers to manage rhythm and pressure, as well as emerging therapies like RyR2 stabilizers and SERCA2a activators aimed at restoring efficient calcium cycling.

Other names
Excitation-contraction couplingCardiac calcium signalingCalcium handling in cardiomyocytes
02

Mechanism of action

Modulation of calcium entry via L-type channels, stabilization of ryanodine receptors to prevent diastolic leak, enhancement of SERCA2a-mediated calcium reuptake, and sensitization of myofilaments to calcium.

03

Biological functions

Signal transductionMuscle contractionElectromechanical couplingIon homeostasis
04

Disease associations

Cardiovascular diseaseHeart failureArrhythmiaHypertrophic cardiomyopathyAtrial fibrillation
05

Safety considerations

Pro-arrhythmic riskNegative inotropic effectsHypotensionHeart blockElectrolyte imbalances
06

Interacting drugs

Verapamil

7 more in the full profile.

07

Biomarkers

B-type natriuretic peptide (BNP)Cardiac troponin ISarcoplasmic reticulum calcium loadPhospholamban phosphorylation status

Beyond the preview

Go deeper on Cardiomyocyte calcium homeostasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiomyocyte calcium homeostasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call